References
- Joint United Nations Programme on HIV/ AIDS, Report on the Global HIV/AIDS Epidemic, Geneva, Switzerland, UNAIDS, 2020. Available at: https://www.unaids.org/en/resources/fact-sheet
- M.A. Navia, P.M. Fitzgerald, B.M. McKeever, C.-T. Leu, J.C. Heimbach, W.K. Herber, I.S. Sigal, P.L. Darke, and J.P. Springer, Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1, Nature 337 (1989), pp. 615–620. doi:https://doi.org/10.1038/337615a0.
- J.E. Foulkes-Murzycki, W.R.P. Scott, and C.A. Schiffer, Hydrophobic sliding: A possible mechanism for drug resistance in human immunodeficiency virus type 1 protease, Structure 15 (2007), pp. 225–233. doi:https://doi.org/10.1016/j.str.2007.01.006.
- Y. Yu, W. Wang, H. Sun, L. Zhang, S. Wu, and W. Liu, Insights into effect of the Asp25/Asp25ʹ protonation states on binding of inhibitors Amprenavir and MKP97 to HIV-1 protease using molecular dynamics simulations and MM-GBSA calculations, SAR QSAR Environ. Res. 32 (2021), pp. 615–641. doi:https://doi.org/10.1080/1062936X.2021.1939149.
- V. Hornak, A. Okur, R.C. Rizzo, and C. Simmerling, HIV-1 protease flaps spontaneously open and reclose in molecular dynamics simulations, Proc. Natl. Acad. Sci. U.S.A. 103 (2006), pp. 915–920. doi:https://doi.org/10.1073/pnas.0508452103.
- M. Miller, M. Jaskólski, J.M. Rao, J. Leis, and A. Wlodawer, Crystal structure of a retroviral protease proves relationship to aspartic protease family, Nature 337 (1989), pp. 576–579. doi:https://doi.org/10.1038/337576a0.
- A.L. Perryman, J.H. Lin, and J.A. McCammon, HIV‐1 protease molecular dynamics of a wild‐type and of the V82F/I84V mutant: Possible contributions to drug resistance and a potential new target site for drugs, Protein Sci. 13 (2004), pp. 1108–1123. doi:https://doi.org/10.1110/ps.03468904.
- F. Clavel and A.J. Hance, HIV drug resistance, N. Engl. J. Med. 350 (2004), pp. 1023–1035. doi:https://doi.org/10.1056/NEJMra025195.
- A.K. Ghosh, H.L. Osswald, and G. Prato, Recent progress in the development of HIV-1 protease inhibitors for the treatment of HIV/AIDS, J. Med. Chem. 59 (2016), pp. 5172–5208.
- A. Jakalian, D.B. Jack, and C.I. Bayly, Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validation, J. Comput. Chem. 23 (2002), pp. 1623–1641. doi:https://doi.org/10.1002/jcc.10128.
- H. Ohtaka, A. Schön, and E. Freire, Multidrug resistance to HIV-1 protease inhibition requires cooperative coupling between distal mutations, Biochemistry 42 (2003), pp. 13659–13666. doi:https://doi.org/10.1021/bi0350405.
- M.J. Todd, I. Luque, A. Velázquez-Campoy, and E. Freire, Thermodynamic basis of resistance to HIV-1 protease inhibition: Calorimetric analysis of the V82F/I84V active site resistant mutant, Biochemistry 39 (2000), pp. 11876–11883. doi:https://doi.org/10.1021/bi001013s.
- J.M. Coffin, HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy, Science 267 (1995), pp. 483–489. doi:https://doi.org/10.1126/science.7824947.
- J. Agniswamy, C.-H. Shen, A. Aniana, J.M. Sayer, J.M. Louis, and I.T. Weber, HIV-1 protease with 20 mutations exhibits extreme resistance to clinical inhibitors through coordinated structural rearrangements, Biochemistry 51 (2012), pp. 2819–2828. doi:https://doi.org/10.1021/bi2018317.
- J.E. Foulkes-Murzycki, C. Rosi, N. Kurt Yilmaz, R.W. Shafer, and C.A. Schiffer, Cooperative effects of drug-resistance mutations in the flap region of HIV-1 protease, ACS Chem. Biol. 8 (2013), pp. 513–518. doi:https://doi.org/10.1021/cb3006193.
- J. Heal, J. Jimenez-Roldan, S.A. Wells, R. Freedman, and R.A. Römer, Inhibition of HIV-1 protease: The rigidity perspective, Bioinformatics 28 (2012), pp. 350–357. doi:https://doi.org/10.1093/bioinformatics/btr683.
- P. Bandyopadhyay, and B. Meher, Drug Resistance of HIV‐1 Protease against JE‐2147: I47V mutation investigated by molecular dynamics simulation, Chem. Biol. Drug Des. 67 (2006), pp. 155–161. doi:https://doi.org/10.1111/j.1747-0285.2006.00348.x.
- R.O. Soares, P.R. Batista, M.G. Costa, L.E. Dardenne, P.G. Pascutti, and M.A. Soares, Understanding the HIV-1 protease nelfinavir resistance mutation D30N in subtypes B and C through molecular dynamics simulations, J. Mol. Graph. Model. 29 (2010), pp. 137–147. doi:https://doi.org/10.1016/j.jmgm.2010.05.007.
- G. Leonis, T. Steinbrecher, and M.G. Papadopoulos, A contribution to the drug resistance mechanism of Darunavir, Amprenavir, Indinavir, and Saquinavir complexes with HIV-1 protease due to flap mutation I50V: A systematic MM–PBSA and thermodynamic integration study, J. Chem. Inf. Model. 53 (2013), pp. 2141–2153.
- H. Tzoupis, G. Leonis, S. Durdagi, V. Mouchlis, T. Mavromoustakos, and M.G. Papadopoulos, Binding of novel fullerene inhibitors to HIV-1 protease: Insight through molecular dynamics and molecular mechanics Poisson–Boltzmann surface area calculations, J. Comput.-Aided Mol. Des. 25 (2011), pp. 959–976. doi:https://doi.org/10.1007/s10822-011-9475-4.
- F. Liu, A.Y. Kovalevsky, Y. Tie, A.K. Ghosh, R.W. Harrison, and I.T. Weber, Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir, J. Mol. Biol. 381 (2008), pp. 102–115. doi:https://doi.org/10.1016/j.jmb.2008.05.062.
- P. Naicker, I. Achilonu, S. Fanucchi, M. Fernandes, M.A. Ibrahim, H.W. Dirr, M.E. Soliman, and Y. Sayed, Structural insights into the South African HIV-1 subtype C protease: Impact of hinge region dynamics and flap flexibility in drug resistance, J. Biomol. Struct. Dyn. 31 (2013), pp. 1370–1380. doi:https://doi.org/10.1080/07391102.2012.736774.
- W.R. Scott and C.A. Schiffer, Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance, Structure 8 (2000), pp. 1259–1265. doi:https://doi.org/10.1016/S0969-2126(00)00537-2.
- S.A. Seibold and R.I. Cukier, A molecular dynamics study comparing a wild‐type with a multiple drug resistant HIV protease: Differences in flap and aspartate 25 cavity dimensions, Proteins Struct. Funct. Bioinf. 69 (2007), pp. 551–565. doi:https://doi.org/10.1002/prot.21535.
- W. Wang and P.A. Kollman, Computational study of protein specificity: The molecular basis of HIV-1 protease drug resistance, Proc. Natl. Acad. Sci. U.S.A. 98 (2001), pp. 14937–14942. doi:https://doi.org/10.1073/pnas.251265598.
- P.A. Kollman, I. Massova, C. Reyes, B. Kuhn, S. Huo, L. Chong, M. Lee, T. Lee, Y. Duan, and W. Wang, Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models, Acc. Chem. Res. 33 (2000), pp. 889–897. doi:https://doi.org/10.1021/ar000033j.
- Y. Xu, and R. Wang, A computational analysis of the binding affinities of FKBP12 inhibitors using the MM‐PB/SA method, Proteins Struct. Funct. Bioinf. 64 (2006), pp. 1058–1068. doi:https://doi.org/10.1002/prot.21044.
- T. Simonson, G. Archontis, and M. Karplus, Free energy simulations come of age: Protein− ligand recognition, Acc. Chem. Res. 35 (2002), pp. 430–437. doi:https://doi.org/10.1021/ar010030m.
- F. Barin, F. Cazein, F. Lot, J. Pillonel, S. Brunet, D. Thierry, F. Damond, F. Brun-Vézinet, J.-C. Desenclos, and C. Semaille, Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003–2006, Aids 21 (2007), pp. 2351–2353. doi:https://doi.org/10.1097/QAD.0b013e3282f15637.
- P. Kar and V. Knecht, Origin of decrease in potency of darunavir and two related antiviral inhibitors against HIV-2 compared to HIV-1 protease, J. Phys. Chem. B 116 (2012), pp. 2605–2614. doi:https://doi.org/10.1021/jp211768n.
- A.Y. Kovalevsky, J.M. Louis, A. Aniana, A.K. Ghosh, and I.T. Weber, Structural evidence for effectiveness of darunavir and two related antiviral inhibitors against HIV-2 protease, J. Mol. Biol. 384 (2008), pp. 178–192. doi:https://doi.org/10.1016/j.jmb.2008.09.031.
- B.H. Hahn, G.M. Shaw, K.M. De, and P.M. Sharp, AIDS as a zoonosis: Scientific and public health implications, Science 287 (2000), pp. 607–614. doi:https://doi.org/10.1126/science.287.5453.607.
- D. Li, J.-G. Han, H. Chen, L. Li, R.-N. Zhao, G. Liu, and Y. Duan, Insights into the structural function of the complex of HIV-1 protease with TMC-126: Molecular dynamics simulations and free-energy calculations, J. Mol. Model. 18 (2012), pp. 1841–1854. doi:https://doi.org/10.1007/s00894-011-1205-2.
- J. Chen, X. Wang, T. Zhu, Q. Zhang, and J.Z. Zhang, A comparative insight into amprenavir resistance of mutations V32I, G48V, I50V, I54V, and I84V in HIV-1 protease based on thermodynamic integration and MM-PBSA methods, J. Chem. Inf. Model. 55 (2015), pp. 1903–1913. doi:https://doi.org/10.1021/acs.jcim.5b00173.
- A.K. Ghosh, J.F. Kincaid, W. Cho, D.E. Walters, K. Krishnan, K.A. Hussain, Y. Koo, H. Cho, C. Rudall, and L. Holland, Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino) sulfonamide isostere, Bioorg. Med. Chem. Lett. 8 (1998), pp. 687–690. doi:https://doi.org/10.1016/S0960-894X(98)00098-5.
- H. Ohtaka, A. Velázquez‐Campoy, D. Xie, and E.J.P.S. Freire, Overcoming drug resistance in HIV‐1 chemotherapy: The binding thermodynamics of Amprenavir and TMC‐126 to wild‐type and drug‐resistant mutants of the HIV‐1 protease, Protein Sci. 11 (2002), pp. 1908–1916. doi:https://doi.org/10.1110/ps.0206402.
- K. Yoshimura, R. Kato, M.F. Kavlick, A. Nguyen, V. Maroun, K. Maeda, K.A. Hussain, A.K. Ghosh, S.V. Gulnik, and J.W. Erickson, A potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TMC-126), and selection of a novel (A28S) mutation in the protease active site, J. Virol. 76 (2002), pp. 1349–1358. doi:https://doi.org/10.1128/JVI.76.3.1349-1358.2002.
- T. Cihlar, G.-X. He, X. Liu, J.M. Chen, M. Hatada, S. Swaminathan, M.J. McDermott, Z.-Y. Yang, A.S. Mulato, and X. Chen, Suppression of HIV-1 protease inhibitor resistance by phosphonate-mediated solvent anchoring, J. Mol. Biol. 363 (2006), pp. 635–647. doi:https://doi.org/10.1016/j.jmb.2006.07.073.
- D.A. Case, T.E. Cheatham, T. Darden, H. Gohlke, R. Luo, K.M. Merz, A. Onufriev, C. Simmerling, B. Wang, and R.J. Woods, The Amber biomolecular simulation programs, J. Comput. Chem. 26 (2005), pp. 1668–1688.
- H. Li, A.D. Robertson, and J.H. Jensen, Very fast empirical prediction and rationalization of protein pKa values, Proteins Struct. Funct. Bioinf. 61 (2005), pp. 704–721. doi:https://doi.org/10.1002/prot.20660.
- D.C. Bas, D.M. Rogers, and J.H. Jensen, Very fast prediction and rationalization of pKa values for protein–ligand complexes, Proteins Struct. Funct. Bioinf. 73 (2008), pp. 765–783. doi:https://doi.org/10.1002/prot.22102.
- J.A. Maier, C. Martinez, K. Kasavajhala, L. Wickstrom, K.E. Hauser, and C. Simmerling, ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB, J. Chem. Theory Comput. 11 (2015), pp. 3696–3713. doi:https://doi.org/10.1021/acs.jctc.5b00255.
- J. Wang, R.M. Wolf, J.W. Caldwell, P.A. Kollman, and D.A. Case, Development and testing of a general amber force field, J. Comput. Chem. 25 (2004), pp. 1157–1174. doi:https://doi.org/10.1002/jcc.20035.
- J. Wang, W. Wang, P.A. Kollman, and D.A. Case, Antechamber: An accessory software package for molecular mechanical calculations, J. Am. Chem. Soc. 222 (2001), pp. U403.
- D.A. Case, R.M. Betz, D.S. Cerutti, T.E.I. Cheatham, T.A. Darden, R.E. Duke, T.J. Giese, H. GohIke, A.W. Goetz, N. Homeyer, S. Lzadi, P. Janowski, J. Kaus, A. Kovalenko, T.S. Lee, S. LeGrand, P. Li, C. Lin, T. Luchko, R. Luo, B. Madej, D. Mermelstein, K.M. Merz, G. Monard, H. Nguyen, H.T. Nguyen, I. Omelyan, A. Onufriev, D.R. Roe, A. Roitberg, C. Sagui, C.L. Simmerling, W.M. Botello-Smith, J. Swails, R.C. Walker, J. Wang, R.M. Wolf, X. Wu, L. Xiao, and P.A. Kollman, Amber 2016, University of California, San Francisco, 2016.
- D.J. Price and C.L. Brooks III, A modified TIP3P water potential for simulation with Ewald summation, J. Chem. Phys. 121 (2004), pp. 10096–10103. doi:https://doi.org/10.1063/1.1808117.
- W.L. Jorgensen, J. Chandrasekhar, J.D. Madura, R.W. Impey, and M.L. Klein, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys. 79 (1983), pp. 926–935. doi:https://doi.org/10.1063/1.445869.
- J.-P. Ryckaert, G. Ciccotti, and H.J. Berendsen, Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes, J. Comput. Phys. 23 (1977), pp. 327–341. doi:https://doi.org/10.1016/0021-9991(77)90098-5.
- M.G. Paterlini and D.M. Ferguson, Constant temperature simulations using the Langevin equation with velocity Verlet integration, Chem. Phys. 236 (1998), pp. 243–252. doi:https://doi.org/10.1016/S0301-0104(98)00214-6.
- T. Darden, D. York, and L. Pedersen, Particle mesh Ewald: An N⋅ log (N) method for Ewald sums in large systems, J. Chem. Phys. 98 (1993), pp. 10089–10092. doi:https://doi.org/10.1063/1.464397.
- H.J. Berendsen, J.V. Postma, W.F. van Gunsteren, A. DiNola, and J. Haak, Molecular dynamics with coupling to an external bath, J. Chem. Phys. 81 (1984), pp. 3684–3690. doi:https://doi.org/10.1063/1.448118.
- M.F. Sk, N.A. Jonniya, and P. Kar, Exploring the energetic basis of binding of currently used drugs against HIV-1 subtype CRF01_AE protease via molecular dynamics simulations, J. Biomol. Struct. Dyn. 39 (2020), pp. 5892–5909. doi:https://doi.org/10.1080/07391102.2020.1794965.
- S. Jakhmola, N.A. Jonniya, M.F. Sk, A. Rani, P. Kar, and H.C. Jha, Identification of Potential Inhibitors against Epstein–Barr virus nuclear antigen 1 (EBNA1): An insight from docking and molecular dynamic simulations, ACS Chem. Neurosci. 12 (2021), pp. 3060–3072. doi:https://doi.org/10.1021/acschemneuro.1c00350.
- N.A. Jonniya, M.F. Sk, and P. Kar, A comparative study of structural and conformational properties of WNK kinase isoforms bound to an inhibitor: Insights from molecular dynamic simulations, J. Biomol. Struct. Dyn. (2020), pp. 1–16. Available at https://www.tandfonline.com/doi/full/https://doi.org/10.1080/07391102.2020.1827035. (accessed on 05 Oct 2020).
- V.H. Masand, M.F. Sk, P. Kar, V. Rastija, and M.E. Zaki, Identification of Food Compounds as inhibitors of SARS-CoV-2 main protease using molecular docking and molecular dynamics simulations, Chemom. Intell. Lab. Syst. 217 (2021), pp. 104394. doi:https://doi.org/10.1016/j.chemolab.2021.104394. (accessed on 05 Oct 2020).
- R. Roy, M.F. Sk, N.A. Jonniya, S. Poddar, and P. Kar, Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies, J. Biomol. Struct. Dyn. (2021), 1–13. Available at https://www.tandfonline.com/doi/full/https://doi.org/10.1080/07391102.2021.1897680. (accessed on 08 Mar 2021).
- N.A. Jonniya, M.F. Sk, and P. Kar, Investigating Phosphorylation-induced conformational changes in WNK1 kinase by molecular dynamics simulations, ACS Omega 4 (2019), pp. 17404–17416. doi:https://doi.org/10.1021/acsomega.9b02187.
- P. Kar, R. Lipowsky, and V. Knecht, Importance of polar solvation and configurational entropy for design of antiretroviral drugs targeting HIV-1 protease, J. Phys. Chem. B 117 (2013), pp. 5793–5805. doi:https://doi.org/10.1021/jp3085292.
- U. Shankar, N. Jain, S.K. Mishra, M.F. Sk, P. Kar, and A. Kumar, Mining of Ebola virus genome for the construction of multi-epitope vaccine to combat its infection, J. Biomol. Struct. Dyn. 39 (2021), pp. 1–17. doi:https://doi.org/10.1080/07391102.2021.1874529.
- S. Singh, M.F. Sk, A. Sonawane, P. Kar, and S. Sadhukhan, Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA‐dependent RNA polymerase (RdRp) inhibition: An in-silico analysis, J. Biomol. Struct. Dyn. 39 (2021), pp. 6249–6264. doi:https://doi.org/10.1080/07391102.2020.1796810.
- M.F. Sk, N.A. Jonniya, R. Roy, S. Poddar, and P. Kar, Computational investigation of structural dynamics of SARS-CoV-2 methyltransferase-stimulatory factor heterodimer nsp16/nsp10 bound to the cofactor SAM, Front. Mol. Biosci. 7 (2020), pp. 353. doi:https://doi.org/10.3389/fmolb.2020.590165.
- M.F. Sk, R. Roy, N.A. Jonniya, S. Poddar, and P. Kar, Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations, J. Biomol. Struct. Dyn. 39 (2021), pp. 3649–3661. doi:https://doi.org/10.1080/07391102.2020.1768149.
- M. Karplus and J.N. Kushick, Method for estimating the configurational entropy of macromolecules, Macromolecules 14 (1981), pp. 325–332. doi:https://doi.org/10.1021/ma50003a019.
- H. Gohlke, C. Kiel, and D.A. Case, Insights into protein–protein binding by binding free energy calculation and free energy decomposition for the Ras–Raf and Ras–RalGDS complexes, J. Mol. Biol. 330 (2003), pp. 891–913. doi:https://doi.org/10.1016/S0022-2836(03)00610-7.
- T.D. Goddard, C.C. Huang, E.C. Meng, E.F. Pettersen, G.S. Couch, J.H. Morris, and T.E. Ferrin, UCSF ChimeraX: Meeting modern challenges in visualization and analysis, Protein Sci. 27 (2018), pp. 14–25. doi:https://doi.org/10.1002/pro.3235.
- S. Chetty, S. Bhakat, A.J. Martin, and M.E. Soliman, Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: Molecular dynamics insights, J. Biomol. Struct. Dyn. 34 (2016), pp. 135–151. doi:https://doi.org/10.1080/07391102.2015.1018326.
- Z. Zhu, D.I. Schuster, and M.E. Tuckerman, Molecular dynamics study of the connection between flap closing and binding of fullerene-based inhibitors of the HIV-1 protease, Biochemistry 42 (2003), pp. 1326–1333. doi:https://doi.org/10.1021/bi020496s.
- G. Tóth and A. Borics, Flap opening mechanism of HIV-1 protease, J. Mol. Graph. Model. 24 (2006), pp. 465–474. doi:https://doi.org/10.1016/j.jmgm.2005.08.008.
- S.K. Sadiq and G. De Fabritiis, Explicit solvent dynamics and energetics of HIV‐1 protease flap opening and closing, Proteins Struct. Funct. Bioinf. 78 (2010), pp. 2873–2885. doi:https://doi.org/10.1002/prot.22806.
- B. Chakrabarty and N. Parekh, NAPS: Network analysis of protein structures, Nucleic Acids Res. 44 (2016), pp. W375–W382. doi:https://doi.org/10.1093/nar/gkw383.
- M.F. Sk, R. Roy, and P. Kar, Exploring the potency of currently used drugs against HIV-1 protease of subtype D variant by using multiscale simulations, J. Biomol. Struct. Dyn. 39 (2020), pp. 988–1003. doi:https://doi.org/10.1080/07391102.2020.1724196.
- P. Kar, R. Lipowsky, and V. Knecht, Importance of polar solvation for cross-reactivity of antibody and its variants with steroids, J. Phys. Chem. B 115 (2011), pp. 7661–7669. doi:https://doi.org/10.1021/jp201538t.
- V. Knecht, Model amyloid peptide B18 monomer and dimer studied by replica exchange molecular dynamics simulations, J. Phys. Chem. B 114 (2010), pp. 12701–12707. doi:https://doi.org/10.1021/jp1048698.
- T. Hou and R. Yu, Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: Mechanism for binding and drug resistance, J. Med. Chem. 50 (2007), pp. 1177–1188. doi:https://doi.org/10.1021/jm0609162.
- T.D. Wu, C.A. Schiffer, M.J. Gonzales, J. Taylor, R. Kantor, S. Chou, D. Israelski, A.R. Zolopa, W.J. Fessel, and R.W. Shafer, Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments, J. Virol. 77 (2003), pp. 4836–4847. doi:https://doi.org/10.1128/JVI.77.8.4836-4847.2003.